The use of restricted mean survival time to estimate treatment effect under model misspecification, a simulation study

Autor: Alger, Emily, Robertson, David S., Burdon, Abigail J.

The use of the non-parametric Restricted Mean Survival Time endpoint (RMST) has grown in popularity as trialists look to analyse time-to-event outcomes without the restrictions of the proportional hazards assumption. In this paper, we evaluate the po

Externí odkaz: http://arxiv.org/abs/2311.01872

Statistical methods and data visualisation of patient-reported outcomes in early phase dose-finding oncology trials: a methodological review

Autor: Alger, Emily, Minchom, Anna, Lee Aiyegbusi, Olalekan, Schipper, Matthew, Yap, Christina

Publikováno v: In eClinicalMedicine October 2023 64

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Longitudinal Study of the General Knowledge of 4-H Horse Members.

Autor: Nadeau, Jenifer, McCabe Alger, Emily, Hoagland, Tom

Publikováno v: Journal of Extension; Oct2007, Vol. 45 Issue 5, p18-18, 1p

Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and Barriers.

Autor: Spencer K; Department of Medicine at NYU Grossman School of Medicine, NYU Langone Perlmutter Cancer Center, New York, NY., Butenschoen H; Department of Medicine at NYU Grossman School of Medicine, NYU Langone Perlmutter Cancer Center, New York, NY., Alger E; The Alan Turing Institute, London, United Kingdom., Bachini M; Cholangiocarcinoma Foundation, Herriman, UT., Cook N; University of Manchester and the Christie NHS Foundation Trust, Manchester, United Kingdom.

Publikováno v: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2024 Jun; Vol. 44 (3), pp. e433648.